Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT-Reference-Cited by-同舟云学术

Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT

Published:2023-12 Issue:6 Volume:30 Page:2454-2463
ISSN:1071-3581
Container-title:Journal of Nuclear Cardiology
language:en
Short-container-title:Journal of Nuclear Cardiology

Author:

Chan Shan-Ho,Huang Cheng-Kai,Luzhbin Dmytro,Hou Po-Nien,Chang Yu-Ting,Wu Jay

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s12350-023-03296-2.pdf

Reference18 articles.

1. Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring;Chareonthaitawee;J Nucl Cardiol,2017

2. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for diagnosis of cardiac sarcoidosis-2018 update: Japanese Society of Nuclear Cardiology recommendations;Kumita;J Nucl Cardiol,2019

3. Effective suppression of myocardial glucose uptake using predesigned low-carbohydrate boxed meals;Huang;J Nucl Cardiol.,2022

4. Use of unfractionated heparin for the suppression of myocardial glucose metabolism in (18)F-FDG PET/CT studies;Suárez Fernández;Rev Esp Med Nucl Imagen Mol,2021

5. Suppression of myocardial glucose metabolism in FDG PET/CT: Impact of dose variation in heparin bolus pre-administration;Scholtens;Eur J Nucl Med Mol Imaging,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can FDG PET Serve as a Clinically Relevant Tool for Detecting Active Non-sarcoidotic Myocarditis?;Nuclear Medicine and Molecular Imaging;2023-10-31